Wills Financial Group, Inc. Charles River Laboratories International, Inc. Transaction History

Wills Financial Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$204.13 - $302.4 $71,241 - $105,537	-349 Reduced 9.57%	3,296 $705,000
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $130,310 - $184,676	-510 Reduced 12.27%	3,645 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $593,129 - $757,371	1,688 Added 68.42%	4,155 $1.57 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $9,688 - $11,915	26 Added 1.07%	2,467 $1.02 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $94,134 - $118,928	320 Added 15.09%	2,441 $902,000
Q1 2021 May 12, 2021	BUY	$249.67 - $299.48 $529,550 - $635,197	2,121 New	2,121 $614,000

710

53.9M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.51B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Wills Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Wills Financial Group, Inc. with notifications on news.